Literature DB >> 24283220

Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India.

Venkatesan Chakrapani1, Jaikumar Velayudham, Murali Shunmugam, Peter A Newman, Robert Dubrow.   

Abstract

India's National AIDS Control Organization provides free antiretroviral treatment (ART) to people living with HIV (PLHIV), including members of marginalized groups such as injecting drug users (IDUs). To help inform development of interventions to enhance ART access, we explored barriers to free ART access at government ART centers for IDUs living with HIV in Chennai by conducting three focus groups (n = 19 IDUs) and four key informant interviews. Data were explored using framework analysis to identify categories and derive themes. We found interrelated barriers at the family and social, health-care system, and individual levels. Family and social level barriers included lack of family support and fear of societal discrimination, as well as unmet basic needs, including food and shelter. Health-care system barriers included actual or perceived unfriendly hospital environment and procedures such as requiring proof of address and identity from PLHIV, including homeless IDUs; provider perception that IDUs will not adhere to ART, resulting in ART not being initiated; actual or perceived inadequate counseling services and lack of confidentiality; and lack of effective linkages between ART centers, needle/syringe programs, and drug dependence treatment centers. Individual-level barriers included active drug use, lack of self-efficacy in ART adherence, low motivation to initiate ART stemming from a fatalistic attitude, and inadequate knowledge about ART. These findings indicate that to facilitate IDUs gaining access to ART, systemic changes are needed, including steps to make the environment and procedures at government ART centers more IDU-friendly and steps to decrease HIV- and drug use-related stigma and discrimination faced by IDUs from the general public and health-care providers. Housing support for homeless IDUs and linkage of IDUs with drug dependence treatment are also essential.

Entities:  

Keywords:  AIDS; HIV; India; access to health care; antiretroviral treatment; injecting drug users

Mesh:

Substances:

Year:  2013        PMID: 24283220      PMCID: PMC4017592          DOI: 10.1080/09540121.2013.861573

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  25 in total

1.  Scale-up of opioid substitution therapy in India: opportunities and challenges.

Authors:  M Suresh Kumar; Alok Agrawal
Journal:  Int J Drug Policy       Date:  2012-01-26

2.  Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group.

Authors:  J P Moatti; M P Carrieri; B Spire; J A Gastaut; J P Cassuto; J Moreau
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

3.  Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment.

Authors:  Mukta Sharma; Rajkumar Raju Singh; Phillip Laishram; Basanta Kumar; Haobam Nanao; Charan Sharma; Tanvir Ahmed
Journal:  Int J Drug Policy       Date:  2007-06-21

Review 4.  A review of barriers and facilitators of HIV treatment among injection drug users.

Authors:  Evan Wood; Thomas Kerr; Mark W Tyndall; Julio S G Montaner
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

5.  Barriers to free antiretroviral treatment access for female sex workers in Chennai, India.

Authors:  Venkatesan Chakrapani; Peter A Newman; Murali Shunmugam; Abraham K Kurian; Robert Dubrow
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

6.  Drug abuse, methadone treatment, and health services use among injection drug users with AIDS.

Authors:  U Sambamoorthi; L A Warner; S Crystal; J Walkup
Journal:  Drug Alcohol Depend       Date:  2000-07-01       Impact factor: 4.492

7.  Delivery models of opioid agonist maintenance treatment in South Asia: a good beginning.

Authors:  Ravindra Rao; Alok Agrawal; Kunal Kishore; Atul Ambekar
Journal:  Bull World Health Organ       Date:  2013-02-01       Impact factor: 9.408

8.  Barriers to free antiretroviral treatment access among kothi-identified men who have sex with men and aravanis (transgender women) in Chennai, India.

Authors:  Venkatesan Chakrapani; Peter A Newman; Murali Shunmugam; Robert Dubrow
Journal:  AIDS Care       Date:  2011-06-14

Review 9.  Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.

Authors:  Daniel Wolfe; M Patrizia Carrieri; Donald Shepard
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

10.  The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India.

Authors:  Carl Latkin; Aylur K Srikrishnan; Cui Yang; Sethulakshmi Johnson; Sunil S Solomon; Suresh Kumar; David D Celentano; Suniti Solomon
Journal:  Drug Alcohol Depend       Date:  2010-05-13       Impact factor: 4.492

View more
  30 in total

1.  Antiretroviral therapy adherence and self-efficacy among people living with HIV and a history of drug use in Vietnam.

Authors:  Li Li; Chunqing Lin; Sung-Jae Lee; Le Anh Tuan; Nan Feng; Nguyen Anh Tuan
Journal:  Int J STD AIDS       Date:  2017-03-03       Impact factor: 1.359

2.  Stigma towards people who use drugs: A case vignette study in methadone maintenance treatment clinics in China.

Authors:  Sitong Luo; Chunqing Lin; Nan Feng; Zunyou Wu; Li Li
Journal:  Int J Drug Policy       Date:  2019-06-21

3.  Getting to 90: linkage to HIV care among men who have sex with men and people who inject drugs in India.

Authors:  Allison M McFall; Shruti H Mehta; Aylur K Srikrishnan; Gregory M Lucas; Canjeevaram K Vasudevan; David D Celentano; Muniratnam S Kumar; Suniti Solomon; Sunil S Solomon
Journal:  AIDS Care       Date:  2016-04-07

4.  Readiness for Antiretroviral Therapy: Implications for Linking HIV-Infected Individuals to Care and Treatment.

Authors:  Brendan Maughan-Brown; Philip Smith; Caroline Kuo; Abigail Harrison; Mark N Lurie; Linda-Gail Bekker; Omar Galárraga
Journal:  AIDS Behav       Date:  2018-03

5.  Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.

Authors:  Mary Clare Kennedy; Thomas H Kerr; Evan Wood; Jeannie A Shoveller; Julio S G Montaner; M-J S Milloy
Journal:  AIDS       Date:  2018-05-15       Impact factor: 4.177

Review 6.  Quality of Care and Service Expansion for HIV Care and Treatment.

Authors:  Carolyn Bolton Moore; Erica Ciaraldi
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

7.  HIV stigma is a barrier to achieving 90-90-90 in India.

Authors:  Maria L Ekstrand; Shalini Bharat; Krishnamachari Srinivasan
Journal:  Lancet HIV       Date:  2018-10-08       Impact factor: 12.767

Review 8.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

9.  Integrating antiretroviral therapy in methadone maintenance therapy clinics: service provider perceptions.

Authors:  Chunqing Lin; Xiaobin Cao; Li Li
Journal:  Int J Drug Policy       Date:  2014-05-10

10.  Reducing HIV stigma among healthcare providers in India using a partly tablet-administered intervention: the DriSti trial.

Authors:  Maria L Ekstrand; Tony Raj; Elsa Heylen; Laura Nyblade; Dhinagaran Devdass; Matilda Pereira; Amanda Mazur; Krishnamachari Srinivasan
Journal:  AIDS Care       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.